DefiniGEN is Osiris Therapeutics's #1 rival. DefiniGEN is a Private company that was founded in Cambridge, England in 2013. Like Osiris Therapeutics, DefiniGEN also works within the Biotechnology field. DefiniGEN has 337 fewer employees vs. Osiris Therapeutics.
Novadip is perceived as one of Osiris Therapeutics's biggest rivals. Novadip was founded in 2013, and is headquartered in Mont-saint-guibert, Walloon Brabant. Like Osiris Therapeutics, Novadip also operates in the Biotechnology sector. Novadip generates $147M less revenue vs. Osiris Therapeutics.
Axiogenesis is a top competitor of Osiris Therapeutics. Axiogenesis is a Private company that was founded in 2000 in Cologne, North Rhine-Westphalia. Like Osiris Therapeutics, Axiogenesis also operates in the Biotechnology space. Compared to Osiris Therapeutics, Axiogenesis has 294 fewer employees.